Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
2
Number of overlapping holdings
5.6%
% of IHE's 37 holdings also in OZEM
9.5%
% of OZEM's 22 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 25.8% | 16.9% | 16.9% |
|
PFIZER INC | 4.3% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 24.4% |
|
ELI LILLY & CO | 8.9% |
|
ROYALTY PHARMA PLC CLASS A | 5.0% |
|
ZOETIS INC | 4.6% |
|
MERCK & CO. INC. | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% |
|
VIATRIS, INC. | 4.1% |
 |
JAZZ PHARMACEUTICALS PLC | 2.9% |
|
CORCEPT THERAPEUTICS INC | 2.7% |
|
AXSOME THERAPEUTICS, INC. | 2.0% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.2% |
 |
ROCHE HOLDING LTD | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ZEALAND PHARMA A/S | -4.6% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.1% |
|
AMGEN INC | -3.0% |